Literature DB >> 10952618

Activities of antimicrobial agents against intracellular pneumococci.

G L Mandell1, E J Coleman.   

Abstract

Pneumococci can enter and survive inside human lung alveolar carcinoma cells. We examined the activity of azithromycin, gentamicin, levofloxacin, moxifloxacin, penicillin G, rifampin, telithromycin, and trovafloxacin against pneumococci inside and outside cells. We found that moxifloxacin, trovafloxacin, and telithromycin were the most active, but only telithromycin killed all intracellular organisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952618      PMCID: PMC90108          DOI: 10.1128/AAC.44.9.2561-2563.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.

Authors:  A Pascual; I García; S Ballesta; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Microbiologic characteristics of persistent otitis media.

Authors:  I Brook; A E Gober
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-12

3.  Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.

Authors:  J M Hamilton-Miller; S Shah
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

4.  Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Preira; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 5.  The importance of penetration of antimicrobial agents into cells.

Authors:  J C Schwab; G L Mandell
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

6.  The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells.

Authors:  C Miossec-Bartoli; L Pilatre; P Peyron; E N N'Diaye; V Collart-Dutilleul; I Maridonneau-Parini; A Diu-Hercend
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 7.  Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract.

Authors:  R Wise; D Honeybourne
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

8.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Antibiotic entry into human polymorphonuclear leukocytes.

Authors:  R C Prokesch; W L Hand
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLS.

Authors:  P Rous; F S Jones
Journal:  J Exp Med       Date:  1916-05-01       Impact factor: 14.307

View more
  5 in total

1.  Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model.

Authors:  Delphine Paillard; Jean Grellet; Véronique Dubois; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Authors:  Christina Kratzer; Wolfgang Graninger; Karin Macfelda; Astrid Buxbaum; Apostolos Georgopoulos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 3.  The ketolides: a critical review.

Authors:  George G Zhanel; Michael Walters; Ayman Noreddin; Lavern M Vercaigne; Aleksandra Wierzbowski; John M Embil; Alfred S Gin; Stephen Douthwaite; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Multi-species bacterial biofilm and intracellular infection in otitis media.

Authors:  Ruth B Thornton; Paul J Rigby; Selma P Wiertsema; Pierre Filion; Jennifer Langlands; Harvey L Coates; Shyan Vijayasekaran; Anthony D Keil; Peter C Richmond
Journal:  BMC Pediatr       Date:  2011-10-24       Impact factor: 2.125

5.  A bacteriophage endolysin that eliminates intracellular streptococci.

Authors:  Yang Shen; Marilia Barros; Tarek Vennemann; D Travis Gallagher; Yizhou Yin; Sara B Linden; Ryan D Heselpoth; Dennis J Spencer; David M Donovan; John Moult; Vincent A Fischetti; Frank Heinrich; Mathias Lösche; Daniel C Nelson
Journal:  Elife       Date:  2016-03-15       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.